The miniature models could exponentially accelerate vaccine development, cancer treatment research, and improved health outcomes across a spectrum of diseases. The left image shows the immune organ-on ...

In April, the FDA announced an ambitious plan to phase out animal testing requirements for monoclonal antibodies and other therapies in an effort to improve drug safety and reduce R&D costs. The goal ...